These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9218939)

  • 1. Role of growth factors in benign prostatic hyperplasia.
    Lawson RK
    Eur Urol; 1997; 32 Suppl 1():22-7. PubMed ID: 9218939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of angiogenesis in bladder response to partial outlet obstruction.
    Levin R; Chichester P; Levin S; Buttyan R
    Scand J Urol Nephrol Suppl; 2004; (215):37-47. PubMed ID: 15545195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular aspects of bladder hypertrophy.
    Levin RM; Levin SS; Zhao Y; Buttyan R
    Eur Urol; 1997; 32 Suppl 1():15-21. PubMed ID: 9218938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
    Parsons JK
    J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation.
    Cho KS; Kim J; Choi YD; Kim JH; Hong SJ
    Med Hypotheses; 2008; 70(3):532-5. PubMed ID: 17761390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
    Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
    Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of clinical benign prostatic hyperplasia.
    Shapiro E; Lepor H
    Urol Clin North Am; 1995 May; 22(2):285-90. PubMed ID: 7539174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of the factors on benign prostatic hyperplasia combined with obstruction].
    Chen Q; Wang YX
    Zhonghua Nan Ke Xue; 2002; 8(4):299-301. PubMed ID: 12491701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detrusor muscle: an innocent victim of bladder outlet obstruction.
    Mirone V; Imbimbo C; Longo N; Fusco F
    Eur Urol; 2007 Jan; 51(1):57-66. PubMed ID: 16979287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of benign prostatic hyperplasia.
    Roehrborn CG
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S11-8. PubMed ID: 19002119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of bladder outlet obstruction and molecular insights into the basis for the development of bladder dysfunction.
    Buttyan R; Chen MW; Levin RM
    Eur Urol; 1997; 32 Suppl 1():32-9. PubMed ID: 9218941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral Tadenan treatment on rabbit bladder structure and function after partial outlet obstruction.
    Levin RM; Hass MA; Bellamy F; Horan P; Whitbeck K; Chow PH; Kung LS; Gosling J
    J Urol; 2002 May; 167(5):2253-9. PubMed ID: 11956488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign prostatic hyperplasia: does lifestyle play a role?
    Barnard RJ; Aronson WJ
    Phys Sportsmed; 2009 Dec; 37(4):141-6. PubMed ID: 20048551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostatic growth factors and benign hypertrophy of the prostate. Current knowledge and perspectives].
    Desgrandchamps F; Tatoud R; Cussenot O; Teillac P; Le Duc A
    Prog Urol; 1992 Dec; 2(6):1031-44. PubMed ID: 1284554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign prostatic hyperplasia.
    Jonler M; Riehmann M; Brinkmann R; Bruskewitz RC
    Endocrinol Metab Clin North Am; 1994 Dec; 23(4):795-807. PubMed ID: 7535688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of severe bladder wall hypertrophy: bladder cancer or sequela of bladder outlet obstruction?
    Tyson M; French M; McNulty N; Lerner L
    Can J Urol; 2009 Feb; 16(1):4516-8. PubMed ID: 19222895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and symptom scores in BPH.
    Reynard J; Abrams P
    Scand J Urol Nephrol Suppl; 1994; 157():137-45. PubMed ID: 7524140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.